ATG5 Gene: Autophagy Related 5
A key regulator of autophagy and its implications in human disease
Gene Information Card
| Symbol | ATG5 |
|---|---|
| Full Name | Autophagy Related 5 |
| Gene Type | Protein coding |
| Chromosomal Location | 6q21 |
| NCBI Gene ID | 9474 ncbi.nlm.nih.gov/gene/9474 |
| Ensembl ID | ENSG00000057608 |
| UniProt ID | Q9H1Y0 |
| OMIM ID | 604261 |
| HGNC ID | 589 |
| Aliases | APG5, APG5L, ASP, hAPG5 |
Description
ATG5 (Autophagy Related 5) encodes a protein that is essential for autophagosome formation, a key step in macroautophagy. The ATG5 protein forms a conjugate with ATG12, which then associates with ATG16L1 to form a complex that promotes the lipidation of LC3 (MAP1LC3A) at the autophagosome membrane. This process is critical for the degradation and recycling of cytoplasmic components, including damaged organelles and protein aggregates. ATG5 also plays roles in other cellular processes such as apoptosis, immune response, and tumor suppression. Mutations and dysregulation of ATG5 have been linked to various diseases, including neurodegenerative disorders, inflammatory conditions, and cancer.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Spinocerebellar ataxia type 35 | Biallelic loss-of-function mutations in ATG5 impair autophagy, leading to neuronal degeneration. | OMIM #604261; PMID: 27545674 |
| Ataxia, developmental delay, and intellectual disability | Homozygous missense mutations in ATG5 disrupt autophagosome formation, affecting neurodevelopment. | OMIM #604261; PMID: 27545674 |
| Inflammatory bowel disease (susceptibility) | ATG5 variants may alter autophagy in intestinal epithelium, affecting immune homeostasis. | ClinVar; PMID: 23128233 |
| Cancer (various types) | Dysregulation of ATG5 expression can promote tumorigenesis by modulating autophagy and apoptosis. | COSMIC; PMID: 25644177 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Brain | 10.2 | Medium |
| Heart | 8.5 | Medium |
| Liver | 7.8 | Medium |
| Kidney | 9.1 | Medium |
| Lung | 6.4 | Low |
| Skeletal muscle | 5.2 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HeLa | 12.3 | Cervical cancer cell line; high expression |
| HEK293 | 11.8 | Embryonic kidney; high expression |
| MCF7 | 9.5 | Breast cancer; moderate expression |
| A549 | 8.2 | Lung carcinoma; moderate expression |
| HepG2 | 7.9 | Liver cancer; moderate expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| p.Glu122Asp | Missense | Rare | Impairs ATG5-ATG12 conjugation, reducing autophagy |
| p.Arg134His | Missense | Rare | Disrupts ATG5-ATG16L1 interaction, affecting autophagosome formation |
| c.IVS1+1G>A | Splice site | Rare | Splicing defect leading to loss of function |
| p.Leu200Phe | Missense | Rare | Alters protein stability and autophagy activity |
Mutation functional classification
Loss of Function (LOF)
Loss-of-function mutations in ATG5 impair autophagosome formation, leading to accumulation of damaged proteins and organelles, contributing to neurodegeneration and developmental disorders.
Gain of Function (GOF)
No clear gain-of-function mutations have been reported; ATG5 is primarily a tumor suppressor, and overexpression may promote autophagy but is not typically oncogenic.
Dominant Negative (DN)
Some missense mutations may act in a dominant-negative manner by interfering with the ATG5-ATG12-ATG16L1 complex, but evidence is limited.
View complete mutation data:
Gene Ontology (GO)
| • autophagy | • protein conjugation |
| • ATG12 transferase activity | • ubiquitin-like protein conjugation |
| • autophagosome assembly | • response to starvation |
| • apoptotic process | • cellular response to oxidative stress |
Pathways
• Autophagy - animal
• Mitophagy
• Selective autophagy
• LC3-I to LC3-II conversion
• ATG5-ATG12 conjugation pathway
Protein Summary
The ATG5 protein is a 275-amino acid protein that is essential for autophagy. It forms a covalent conjugate with ATG12 via a ubiquitin-like conjugation system, and this conjugate interacts with ATG16L1 to form a multimeric complex. This complex is required for the lipidation of LC3-I to LC3-II, which is a critical step in autophagosome membrane elongation and closure. ATG5 also has autophagy-independent functions, including roles in apoptosis, antigen presentation, and regulation of innate immune signaling. Its expression is ubiquitous, with higher levels in tissues with high metabolic activity. Mutations in ATG5 are rare but can cause severe neurological phenotypes when biallelic.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| ATG5 Knockout HEK293 Cell Line | EDJ-KQ12467 | Human | 9474 | Details Get a Quote |
| ATG5 Knockout HeLa Cell Line | EDJ-KQ18163 | Human | 9474 | Details Get a Quote |
| ATG5 Knockout A-549 Cell Line | EDJ-KQ41412 | Human | 9474 | Details Get a Quote |
| ATG5 Knockout HCT 116 Cell Line | EDJ-KQ41413 | Human | 9474 | Details Get a Quote |
| ATG5 Knockout Huh-7 Cell Line | EDJ-KZ1 | Human | 9474 | Details Get a Quote |
| ATG5 Knockout NCI-H1299 Cell Line | EDJ-KZ10 | Human | 9474 | Details Get a Quote |
| ATG5 Knockout PK-15 Cell Line | EDJ-KZ100 | Pig | 100739102 | Details Get a Quote |
| ATG5 Knockout E6 Cell Line | EDJ-KZ559 | African green monkey | 103240649 | Details Get a Quote |
Displaying Records 1 To 8 Of 8 Records